Valuation: ConvaTec Group PLC

Market Cap 6.13B 104B 5.26B 4.91B 4.51B 8.48B 586B 8.61B 57.96B 22.7B 294B 23.03B 22.53B 972B P/E 2026 *
24.6x
P/E 2027 * 17.2x
Enterprise Value 7.48B 127B 6.42B 5.99B 5.5B 10.34B 715B 10.51B 70.69B 27.68B 359B 28.08B 27.47B 1,185B EV / Sales 2026 *
2.93x
EV / Sales 2027 * 2.67x
Free-Float
95.17%
Yield 2026 *
2.52%
Yield 2027 * 2.87%
1 year 59.76
Extreme 59.76
59.76
3 years 57.13
Extreme 57.13
74.97
5 years 57.13
Extreme 57.13
74.97
10 years 57.13
Extreme 57.13
74.97
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 71 14/08/2017
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%-.--% - - 6.13B
+1.55%+3.17%-12.82%+10.34% 198B
+2.22%+3.71%+4.71%+15.47% 120B
+0.31%+0.93%+7.60%+75.78% 60.51B
-0.69%-4.97%+30.57%+60.51% 53.64B
+3.78%+2.19%-5.27%-31.46% 51.1B
+0.31%-1.01%+11.10%-15.25% 33.92B
-0.62%-4.48% - - 29.75B
+1.79%+0.14%+42.84%-9.02% 24.83B
+4.23%-1.68%-6.80%+25.10% 23.01B
Average +0.74%-0.28%+8.99%+16.43% 66.14B
Weighted average by Cap. +0.38%+1.42%+2.02%+17.63%

Financials

2026 *2027 *
Net sales 2.56B 43.38B 2.19B 2.05B 1.88B 3.53B 244B 3.59B 24.16B 9.46B 123B 9.6B 9.39B 405B 2.73B 46.36B 2.34B 2.19B 2.01B 3.78B 261B 3.84B 25.82B 10.11B 131B 10.26B 10.03B 433B
Net income 248M 4.21B 213M 199M 182M 343M 23.73B 349M 2.35B 919M 11.9B 932M 912M 39.35B 360M 6.11B 309M 288M 265M 498M 34.41B 506M 3.4B 1.33B 17.26B 1.35B 1.32B 57.06B
Net Debt 1.35B 22.84B 1.15B 1.08B 989M 1.86B 129B 1.89B 12.72B 4.98B 64.52B 5.05B 4.94B 213B 1.15B 19.47B 984M 919M 843M 1.59B 110B 1.61B 10.84B 4.25B 55B 4.31B 4.21B 182B
Logo ConvaTec Group PLC
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,000
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
3.138USD
Average target price
4.033USD
Spread / Average Target
+28.54%

Quarterly revenue - Rate of surprise